Breaking News Instant updates and real-time market news.

OLLI

Ollie's Bargain Outlet

$88.04 /

-1.93 (-2.15%)

06:38
05/29/20
05/29
06:38
05/29/20
06:38

Ollie's Bargain Outlet price target raised to $104 from $54 at Stephens

Stephens analyst Rick Nelson raised the firm's price target on Ollie's Bargain Outlet to $104 from $54 and keeps an Overweight rating on the shares after the company's Q1 earnings came in well above consensus and his own estimates. He is encouraged that same-stores sales growth has rebounded since early April and the "spike" has carried into May, adding that he thinks this demonstrates Ollie's ability to pivot quickly and respond to changing customer demands. Nelson sees Ollie's being a retailer that "should benefit greatly from the shakeout in retail with real estate and canceled order inventory availability," he added.

  • 22

    Jun

OLLI Ollie's Bargain Outlet
$88.04 /

-1.93 (-2.15%)

05/26/20 Craig-Hallum
Ollie's Bargain Outlet upgraded to Buy at Craig-Hallum
05/26/20 Craig-Hallum
Ollie's Bargain Outlet upgraded to Buy from Hold at Craig-Hallum
05/26/20 Credit Suisse
Ollie's Bargain Outlet downgraded to Neutral from Outperform at Credit Suisse
05/18/20
Fly Intel: Top five analyst initiations

TODAY'S FREE FLY STORIES

Periodicals
'Westworld' creators working on 'Fallout' show for Amazon, Variety says » 13:55
07/02/20
07/02
13:55
07/02/20
13:55
T

AT&T

$30.28 /

+0.37 (+1.24%)

, AMZN

Amazon.com

$2,915.80 /

+41.06 (+1.43%)

Jonathan Nolan and Lisa…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
T AT&T
$30.28 /

+0.37 (+1.24%)

AMZN Amazon.com
$2,915.80 /

+41.06 (+1.43%)

T AT&T
$30.28 /

+0.37 (+1.24%)

06/25/20 BTIG
RingCentral price target raised to $325 from $275 at BTIG
06/15/20 Stephens
Electronic Arts seems like best fit as buyer for WB Interactive, says Stephens
06/15/20 Oppenheimer
EA makes 'most sense' as potential buyer of Warner gaming unit, says Oppenheimer
06/11/20 Wells Fargo
T-Mobile price target raised to $120 from $110 at Wells Fargo
AMZN Amazon.com
$2,915.80 /

+41.06 (+1.43%)

06/30/20 Mizuho
Amazon.com price target raised to $3,100 from $2,550 at Mizuho
06/29/20 Monness Crespi
Amazon.com price target raised to $3,500 from $2,800 at Monness Crespi
06/26/20 Baird
Amazon acquiring Zoox could be 'game-changing,' says Baird
06/26/20 SunTrust
Etsy price target raised to $112 from $88 at SunTrust
T AT&T
$30.28 /

+0.37 (+1.24%)

AMZN Amazon.com
$2,915.80 /

+41.06 (+1.43%)

T AT&T
$30.28 /

+0.37 (+1.24%)

AMZN Amazon.com
$2,915.80 /

+41.06 (+1.43%)

T AT&T
$30.28 /

+0.37 (+1.24%)

AMZN Amazon.com
$2,915.80 /

+41.06 (+1.43%)

T AT&T
$30.28 /

+0.37 (+1.24%)

AMZN Amazon.com
$2,915.80 /

+41.06 (+1.43%)

AMZN Amazon.com
$2,915.80 /

+41.06 (+1.43%)

Hot Stocks
Akari's Nomacopan designated as orphan treatment of bullous pemphigoid by EMA » 13:49
07/02/20
07/02
13:49
07/02/20
13:49
AKTX

Akari Therapeutics

$2.42 /

+0.05 (+2.11%)

The European Medicines…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AKTX Akari Therapeutics
$2.42 /

+0.05 (+2.11%)

AKTX Akari Therapeutics
$2.42 /

+0.05 (+2.11%)

Hot Stocks
Baidu unveils 'new infrastructure' plan for the smart economy » 13:34
07/02/20
07/02
13:34
07/02/20
13:34
BIDU

Baidu

$124.48 /

+3.85 (+3.19%)

Baidu announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BIDU Baidu
$124.48 /

+3.85 (+3.19%)

BIDU Baidu
$124.48 /

+3.85 (+3.19%)

09:11 Today Loop Capital
iQIYI price target raised to $23 from $20 at Loop Capital
06/15/20 Mizuho
Baidu valuation 'compelling' on overstated concerns, says Mizuho
05/20/20 KeyBanc
Baidu price target raised to $145 from $136 at KeyBanc
05/20/20 HSBC
Baidu price target raised to $132 from $120 at HSBC
BIDU Baidu
$124.48 /

+3.85 (+3.19%)

BIDU Baidu
$124.48 /

+3.85 (+3.19%)

BIDU Baidu
$124.48 /

+3.85 (+3.19%)

BIDU Baidu
$124.48 /

+3.85 (+3.19%)

Recommendations
Wartsila price target lowered to EUR 7.10 from EUR 7.50 at JPMorgan » 13:32
07/02/20
07/02
13:32
07/02/20
13:32
WRTBY

Wartsila

$0.00 /

+ (+0.00%)

JPMorgan analyst Andreas…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WRTBY Wartsila
$0.00 /

+ (+0.00%)

04/23/20 AlphaValue
Wartsila downgraded to Add from Buy at AlphaValue
04/22/20 Morgan Stanley
Wartsila price target lowered to EUR 8.40 from EUR 9.30 at Morgan Stanley
03/19/20 RBC Capital
Wartsila double-upgraded to Outperform from Underperform at RBC Capital
03/11/20 Morgan Stanley
Wartsila price target lowered to EUR 10.70 from EUR 11.30 at Morgan Stanley
Recommendations
Siemens Healthineers price target lowered to EUR 37.60 at JPMorgan » 13:31
07/02/20
07/02
13:31
07/02/20
13:31
SMMNY

Siemens Healthineers

$0.00 /

+ (+0.00%)

JPMorgan analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SMMNY Siemens Healthineers
$0.00 /

+ (+0.00%)

06/08/20 Citi
Siemens Healthineers upgraded to Buy from Neutral at Citi
06/05/20 Exane BNP Paribas
Siemens Healthineers downgraded to Neutral from Outperform at Exane BNP Paribas
05/26/20 Berenberg
Siemens Healthineers price target raised to EUR 52 from EUR 40 at Berenberg
05/07/20 Morgan Stanley
Siemens Healthineers price target lowered to EUR 37 at Morgan Stanley
Recommendations
Royal Mail price target lowered to 145 GBp from 148 GBp at JPMorgan » 13:27
07/02/20
07/02
13:27
07/02/20
13:27
ROYMY

Royal Mail

$0.00 /

+ (+0.00%)

JPMorgan analyst Samuel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ROYMY Royal Mail
$0.00 /

+ (+0.00%)

06/29/20 UBS
Royal Mail initiated with a Buy at UBS
06/26/20 Barclays
Royal Mail price target lowered to 200 GBp from 250 GBp at Barclays
06/02/20 BofA
Royal Mail reinstated with an Underperform at BofA
05/19/20 Berenberg
Royal Mail price target lowered to 100 GBp from 115 GBp at Berenberg
Periodicals
Moderna CEO tells CNBC vaccine trial on track for July start » 13:27
07/02/20
07/02
13:27
07/02/20
13:27
MRNA

Moderna

$58.21 /

-3.42 (-5.55%)

Following STAT's…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRNA Moderna
$58.21 /

-3.42 (-5.55%)

MRNA Moderna
$58.21 /

-3.42 (-5.55%)

09:18 Today BMO Capital
Moderna mRNA platform supported by Pfizer vaccine data, says BMO Capital
06/30/20 Argus
Moderna initiated with a Buy at Argus
06/30/20 Argus
Moderna initiated with a Buy at Argus
06/26/20 Morgan Stanley
Morgan Stanley says Axios overstates contention on Moderna-NIH vaccine ownership
MRNA Moderna
$58.21 /

-3.42 (-5.55%)

  • 19
    May
  • 12
    Feb
MRNA Moderna
$58.21 /

-3.42 (-5.55%)

MRNA Moderna
$58.21 /

-3.42 (-5.55%)

MRNA Moderna
$58.21 /

-3.42 (-5.55%)

Recommendations
M&G Plc price target lowered to 227 GBp from 235 GBp at JPMorgan » 13:26
07/02/20
07/02
13:26
07/02/20
13:26
MGPUF

M&G Plc

$0.00 /

+ (+0.00%)

JPMorgan analyst Ashik…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MGPUF M&G Plc
$0.00 /

+ (+0.00%)

05/28/20 Deutsche Bank
M&G Plc price target raised to 210 GBp from 200 GBp at Deutsche Bank
04/23/20 Deutsche Bank
M&G Plc price target lowered to 200 GBp from 295 GBp at Deutsche Bank
04/01/20 RBC Capital
M&G Plc upgraded to Outperform from Sector Perform at RBC Capital
03/13/20 JPMorgan
M&G Plc price target lowered to 235 GBp from 297 GBp at JPMorgan
Recommendations
Vestas price target raised to DKK 530 from DKK 470 at JPMorgan » 13:26
07/02/20
07/02
13:26
07/02/20
13:26
VWDRY

Vestas

$0.00 /

+ (+0.00%)

JPMorgan analyst Akash…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VWDRY Vestas
$0.00 /

+ (+0.00%)

VWDRY Vestas
$0.00 /

+ (+0.00%)

06/10/20 Deutsche Bank
Vestas price target raised to DKK 775 from DKK 660 at Deutsche Bank
05/12/20 Pareto
Vestas initiated with a Buy at Pareto
05/06/20 Morgan Stanley
Vestas price target raised to DKK 598 from DKK 551 at Morgan Stanley
04/17/20 Morgan Stanley
Vestas price target lowered to DKK 551 from DKK 563 at Morgan Stanley
Recommendations
Richemont price target raised to CHF 65 from CHF 60 at JPMorgan » 13:25
07/02/20
07/02
13:25
07/02/20
13:25
CFRUY

Richemont

$0.00 /

+ (+0.00%)

JPMorgan analyst Melanie…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CFRUY Richemont
$0.00 /

+ (+0.00%)

07/01/20 RBC Capital
Richemont price target raised to CHF 68 from CHF 65 at RBC Capital
06/30/20 Credit Suisse
Richemont price target raised to CHF 55 from CHF 48 at Credit Suisse
06/26/20 Goldman Sachs
Richemont upgraded to Buy from Neutral at Goldman Sachs
06/23/20 Deutsche Bank
Richemont price target lowered to CHF 76 from CHF 78 at Deutsche Bank
General news
Oil Action: The Baker-Hughes » 13:25
07/02/20
07/02
13:25
07/02/20
13:25

Oil Action: The…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
Becton rallies after Wells says rapid COVID test may come very soon » 13:23
07/02/20
07/02
13:23
07/02/20
13:23
BDX

Becton Dickinson

$240.68 /

-0.84 (-0.35%)

Wells Fargo analyst…

Wells Fargo analyst Lawrence Biegelsen spoke with someone who runs a central diagnostic lab for a "medium health system" who on June 30 received an email from a Becton Dickinson diagnostic account representative that indicated the company's rapid antigen COVID-19 test would be available very soon. Becton has been pursuing a rapid antigen COVID-19 test on its Veritor platform which has 27,000 placements in the U.S. and has indicated it plans to have millions of antigen tests available per week once approved, Biegelsen tells investors in a research note. Assuming 2M tests per week at an average price of $18, the analyst estimates a Veritor COVID-19 antigen test could generate revenue of about $470M per quarter, assuming Becton could sell all of its capacity. Biegelsen does not currently include COVID-19 antigen testing in his model. Therefore, approval would represent upside to estimates, he says. Biegelsen keeps an Overweight rating on Becton Dickinson shares, which are up 1% to $244.38 following the analyst note.

ShowHide Related Items >><<
BDX Becton Dickinson
$240.68 /

-0.84 (-0.35%)

BDX Becton Dickinson
$240.68 /

-0.84 (-0.35%)

13:17 Today Wells Fargo
Becton rapid antigen COVID test may be available very soon, says Wells Fargo
06/25/20 Raymond James
Becton Dickinson price target lowered to $265 from $290 at Raymond James
06/01/20
Fly Intel: Top five analyst initiations
05/31/20 Goldman Sachs
Becton Dickinson initiated with a Buy at Goldman Sachs
BDX Becton Dickinson
$240.68 /

-0.84 (-0.35%)

  • 21
    May
BDX Becton Dickinson
$240.68 /

-0.84 (-0.35%)

Periodicals
Companies race to develop medical-grade versions of cannabis, ABC News reports » 13:19
07/02/20
07/02
13:19
07/02/20
13:19
ARTL

Artelo Biosciences

$1.40 /

+0.12 (+9.38%)

Some companies are…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ARTL Artelo Biosciences
$1.40 /

+0.12 (+9.38%)

ARTL Artelo Biosciences
$1.40 /

+0.12 (+9.38%)

05/13/20 Maxim
Artelo Biosciences downgraded to Hold from Buy at Maxim
07/09/19 Maxim
Artelo Biosciences initiated with a Buy at Maxim
07/09/19 Maxim
Artelo Biosciences initiated with a Buy at Maxim
ARTL Artelo Biosciences
$1.40 /

+0.12 (+9.38%)

Recommendations
Becton rapid antigen COVID test may be available very soon, says Wells Fargo  13:17
07/02/20
07/02
13:17
07/02/20
13:17
BDX

Becton Dickinson

$240.83 /

-0.69 (-0.29%)

 
ShowHide Related Items >><<
BDX Becton Dickinson
$240.83 /

-0.69 (-0.29%)

BDX Becton Dickinson
$240.83 /

-0.69 (-0.29%)

06/25/20 Raymond James
Becton Dickinson price target lowered to $265 from $290 at Raymond James
06/01/20
Fly Intel: Top five analyst initiations
05/31/20 Goldman Sachs
Becton Dickinson initiated with a Buy at Goldman Sachs
05/14/20 Piper Sandler
Becton Dickinson price target raised to $296 from $286 at Piper Sandler
BDX Becton Dickinson
$240.83 /

-0.69 (-0.29%)

  • 21
    May
BDX Becton Dickinson
$240.83 /

-0.69 (-0.29%)

Technical Analysis
NASDAQ market internals summary » 13:17
07/02/20
07/02
13:17
07/02/20
13:17
$NSD

NASDAQ Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
$0.00 /

+ (+0.00%)

Technical Analysis
NYSE market internals summary » 13:16
07/02/20
07/02
13:16
07/02/20
13:16
$NYE

NYSE Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
$0.00 /

+ (+0.00%)

Recommendations
Symrise price target raised to EUR 110 from EUR 104 at Deutsche Bank » 13:14
07/02/20
07/02
13:14
07/02/20
13:14
SYIEY

Symrise

$0.00 /

+ (+0.00%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SYIEY Symrise
$0.00 /

+ (+0.00%)

06/05/20 Deutsche Bank
Deutsche Bank backs Buy on Symrise after management meetings
05/20/20 Kepler Cheuvreux
Symrise upgraded to Buy from Hold at Kepler Cheuvreux
04/29/20 UBS
Symrise price target raised to EUR 93 from EUR 89 at UBS
04/21/20 Liberum
Symrise upgraded to Hold from Sell at Liberum
Recommendations
Straumann price target raised to CHF 920 from CHF 860 at Deutsche Bank » 13:14
07/02/20
07/02
13:14
07/02/20
13:14
SAUHY

Straumann

$0.00 /

+ (+0.00%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SAUHY Straumann
$0.00 /

+ (+0.00%)

06/30/20 JPMorgan
Straumann price target raised to CHF 583 from CHF 549 at JPMorgan
06/10/20 Jefferies
Straumann downgraded to Hold from Buy at Jefferies
05/29/20 Morgan Stanley
Straumann downgraded to Underweight from Overweight at Morgan Stanley
05/29/20 Morgan Stanley
Straumann downgraded to Underweight from Overweight at Morgan Stanley
Recommendations
Novozymes price target raised to DKK 320 from DKK 310 at Deutsche Bank » 13:13
07/02/20
07/02
13:13
07/02/20
13:13
NVZMY

Novozymes

$0.00 /

+ (+0.00%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVZMY Novozymes
$0.00 /

+ (+0.00%)

05/12/20 Credit Suisse
Novozymes downgraded to Underperform from Outperform at Credit Suisse
04/01/20 Goldman Sachs
Novozymes downgraded to Sell from Buy at Goldman Sachs
03/13/20
Goldman Sachs to hold a conference
01/14/20 Exane BNP Paribas
Novozymes downgraded to Neutral from Outperform at Exane BNP Paribas
Recommendations
Kerry Group price target raised to EUR 120 from EUR 112 at Deutsche Bank » 13:13
07/02/20
07/02
13:13
07/02/20
13:13
KRYAY

Kerry Group

$0.00 /

+ (+0.00%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KRYAY Kerry Group
$0.00 /

+ (+0.00%)

07/01/20 Barclays
Kerry Group price target raised to EUR 100 from EUR 95 at Barclays
05/20/20 Kepler Cheuvreux
Kerry Group upgraded to Hold from Reduce at Kepler Cheuvreux
05/12/20 AlphaValue
Kerry Group downgraded to Add from Buy at AlphaValue
05/07/20 Morgan Stanley
Kerry Group price target lowered to EUR 105 from EUR 110 at Morgan Stanley
Periodicals
Moderna falls after STAT says large COVID-19 vaccine study delayed » 13:13
07/02/20
07/02
13:13
07/02/20
13:13
MRNA

Moderna

$57.53 /

-4.1 (-6.65%)

A 30,000-patient trial of…

A 30,000-patient trial of Moderna's coronavirus vaccine candidate which was expected to start next week has been delayed, Damian Garde of STAT reports. Moderna is making changes to the trial plan, which has pushed back the expected start date of the Phase 3 study, Garde says, citing investigators. The investigators, who spoke on condition of anonymity, emphasized that protocol changes are common but said it's not clear how long the start will be delayed, he added. Shares of Moderna are down 5% to $58.64 following the report. Following the STAT report, Moderna CEO Stephane Bancel told CNBC following that the trial is on track to start in July. Reference Link

ShowHide Related Items >><<
MRNA Moderna
$57.53 /

-4.1 (-6.65%)

MRNA Moderna
$57.53 /

-4.1 (-6.65%)

09:18 Today BMO Capital
Moderna mRNA platform supported by Pfizer vaccine data, says BMO Capital
06/30/20 Argus
Moderna initiated with a Buy at Argus
06/30/20 Argus
Moderna initiated with a Buy at Argus
06/26/20 Morgan Stanley
Morgan Stanley says Axios overstates contention on Moderna-NIH vaccine ownership
MRNA Moderna
$57.53 /

-4.1 (-6.65%)

  • 19
    May
  • 12
    Feb
MRNA Moderna
$57.53 /

-4.1 (-6.65%)

MRNA Moderna
$57.53 /

-4.1 (-6.65%)

MRNA Moderna
$57.53 /

-4.1 (-6.65%)

Recommendations
InterContinental price target lowered to 4,050 GBp at Deutsche Bank » 13:12
07/02/20
07/02
13:12
07/02/20
13:12
IHG

InterContinental

$46.42 /

+0.8 (+1.75%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IHG InterContinental
$46.42 /

+0.8 (+1.75%)

IHG InterContinental
$46.42 /

+0.8 (+1.75%)

07/01/20 UBS
InterContinental price target lowered to 3,820 GBp from 3,900 GBp at UBS
07/01/20
Fly Intel: Top five analyst initiations
07/01/20 Credit Suisse
InterContinental initiated with a Neutral at Credit Suisse
06/26/20 Peel Hunt
InterContinental initiated with a Buy at Peel Hunt
IHG InterContinental
$46.42 /

+0.8 (+1.75%)

IHG InterContinental
$46.42 /

+0.8 (+1.75%)

Recommendations
BAE Systems price target lowered to 675 GBp from 695 GBp at Deutsche Bank » 13:11
07/02/20
07/02
13:11
07/02/20
13:11
BAESY

BAE Systems

$0.00 /

+ (+0.00%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BAESY BAE Systems
$0.00 /

+ (+0.00%)

BAESY BAE Systems
$0.00 /

+ (+0.00%)

05/18/20 UBS
BAE Systems price target lowered to 511 GBp from 700 GBp at UBS
04/29/20 JPMorgan
BAE Systems price target lowered to 765 GBp from 775 GBp at JPMorgan
04/29/20 JPMorgan
BAE Systems shares offer 50% upside potential, says JPMorgan
04/27/20 Morgan Stanley
BAE Systems upgraded to Overweight from Equal Weight at Morgan Stanley
BAESY BAE Systems
$0.00 /

+ (+0.00%)

BAESY BAE Systems
$0.00 /

+ (+0.00%)

Recommendations
Anglo American price target lowered to 2,200 GBp at Deutsche Bank » 13:10
07/02/20
07/02
13:10
07/02/20
13:10
NGLOY

Anglo American

$0.00 /

+ (+0.00%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NGLOY Anglo American
$0.00 /

+ (+0.00%)

NGLOY Anglo American
$0.00 /

+ (+0.00%)

06/25/20 UBS
Anglo American price target raised to 1,800 GBp from 1,650 GBp at UBS
06/23/20 Morgan Stanley
Anglo American price target lowered to 1,840 GBp at Morgan Stanley
06/18/20 RBC Capital
Anglo American upgraded to Outperform from Sector Perform at RBC Capital
06/10/20 BMO Capital
Anglo American upgraded to Outperform from Market Perform at BMO Capital
Hot Stocks
Moderna drops 5% to $58.36 after STAT report of COVID trial delay  13:08
07/02/20
07/02
13:08
07/02/20
13:08
MRNA

Moderna

$60.20 /

-1.43 (-2.32%)

 
ShowHide Related Items >><<
MRNA Moderna
$60.20 /

-1.43 (-2.32%)

MRNA Moderna
$60.20 /

-1.43 (-2.32%)

09:18 Today BMO Capital
Moderna mRNA platform supported by Pfizer vaccine data, says BMO Capital
06/30/20 Argus
Moderna initiated with a Buy at Argus
06/30/20 Argus
Moderna initiated with a Buy at Argus
06/26/20 Morgan Stanley
Morgan Stanley says Axios overstates contention on Moderna-NIH vaccine ownership
MRNA Moderna
$60.20 /

-1.43 (-2.32%)

  • 19
    May
  • 12
    Feb
MRNA Moderna
$60.20 /

-1.43 (-2.32%)

MRNA Moderna
$60.20 /

-1.43 (-2.32%)

MRNA Moderna
$60.20 /

-1.43 (-2.32%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.